(RTTNews) - Recursion (RXRX) said that the U.S. Food and Drug Administration has granted the company Fast Track designation for the investigation of REC-2282 for treatment of patients with NF2-mutated ...

Researchers at the University of Plymouth are leading an innovative initiative to advance the study of meningiomas in NF2-related schwannomatosis (NF2-SWN). Meningiomas, often linked to the loss of ...

A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2–positive breast cancer (TUTOR). This is an ASCO ...

It’s important to know that an accurate diagnosis of NF2 can only be made by a physician with expertise in the diagnosis and treatment of neurofibromatosis. Specific diagnostic criteria have been ...

Despite being relatively common, meningiomas – a type of brain tumor that accounts for just over 36% of brain cancer diagnoses – aren’t well-known to most people. That could be because they tend to be ...